Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 15 | $56,359,135 |
| Sells | 175 | $65,747,770 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 27 Mar 2025 19:42 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 25 Mar 2025 | Purchase | 91,309 | 44.747 | 4,085,804 | I |
| 27 Mar 2025 19:42 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 26 Mar 2025 | Purchase | 58,691 | 43.012 | 2,524,417 | I |
| 27 Mar 2025 19:42 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 27 Mar 2025 | Purchase | 50,000 | 43.554 | 2,177,700 | I |
| 18 Mar 2025 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 17 Mar 2025 | Sale | 8,201 | 44.697 | 366,560 | D |
| 18 Mar 2025 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 17 Mar 2025 | Sale | 1,799 | 45.05 | 81,045 | D |
| 14 Mar 2025 21:18 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 12 Mar 2025 | Sale | 1,738 | 44.88 | 78,001 | D |
| 14 Mar 2025 20:33 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 12 Mar 2025 | Sale | 607 | 44.88 | 27,242 | D |
| 14 Mar 2025 20:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 12 Mar 2025 | Sale | 614 | 44.88 | 27,556 | D |
| 14 Mar 2025 20:24 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 12 Mar 2025 | Sale | 676 | 44.88 | 30,339 | D |
| 14 Mar 2025 20:18 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 12 Mar 2025 | Sale | 516 | 44.88 | 23,158 | D |
| 12 Mar 2025 18:00 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 10 Mar 2025 | Sale | 28,784 | 41.746 | 1,201,617 | D |
| 12 Mar 2025 18:00 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 10 Mar 2025 | Sale | 1,216 | 42.313 | 51,453 | D |
| 07 Mar 2025 17:30 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 05 Mar 2025 | Sale | 9,338 | 44.401 | 414,617 | D |
| 07 Mar 2025 17:30 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 05 Mar 2025 | Sale | 3,162 | 44.9 | 141,974 | D |
| 05 Mar 2025 18:56 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 04 Mar 2025 | Sale | 11,447 | 44.168 | 505,591 | D |
| 05 Mar 2025 18:56 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 04 Mar 2025 | Sale | 38,553 | 45.071 | 1,737,622 | D |
| 05 Mar 2025 18:55 | AKRO | Akero Therapeutics Inc | LAMY PATRICK | Senior VP, Commercial Strategy | 03 Mar 2025 | Sale | 1,000 | 48.09 | 48,090 | D |
| 21 Feb 2025 17:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 18 Feb 2025 | Sale | 9,100 | 49.79 | 453,089 | D |
| 21 Feb 2025 17:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 18 Feb 2025 | Sale | 900 | 50.634 | 45,571 | D |
| 11 Feb 2025 21:30 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 10 Feb 2025 | Sale | 12,640 | 51.752 | 654,145 | D |
| 11 Feb 2025 21:30 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 10 Feb 2025 | Sale | 6,439 | 52.908 | 340,675 | D |
| 11 Feb 2025 21:30 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 10 Feb 2025 | Sale | 9,972 | 53.666 | 535,157 | D |
| 11 Feb 2025 21:30 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 10 Feb 2025 | Sale | 749 | 54.546 | 40,855 | D |
| 11 Feb 2025 21:30 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 10 Feb 2025 | Sale | 200 | 55.81 | 11,162 | D |
| 07 Feb 2025 19:54 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 30 Jan 2025 | Purchase | 200,000 | 48 | 9,600,000 | I |
| 07 Feb 2025 18:05 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 05 Feb 2025 | Sale | 12,847 | 56.325 | 723,607 | D |
| 07 Feb 2025 18:05 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 05 Feb 2025 | Sale | 5,903 | 56.924 | 336,022 | D |
| 05 Feb 2025 09:03 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 03 Feb 2025 | Sale | 5,100 | 53.565 | 273,182 | D |
| 05 Feb 2025 09:03 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 03 Feb 2025 | Sale | 4,900 | 54.057 | 264,879 | D |
| 31 Jan 2025 09:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 27 Jan 2025 | Sale | 17,000 | 55.156 | 937,652 | D |
| 31 Jan 2025 09:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 27 Jan 2025 | Sale | 9,250 | 55.949 | 517,528 | D |
| 31 Jan 2025 09:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 27 Jan 2025 | Sale | 27,340 | 57.024 | 1,559,036 | D |
| 31 Jan 2025 09:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 27 Jan 2025 | Sale | 25,907 | 55.152 | 1,428,823 | D |
| 31 Jan 2025 09:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 27 Jan 2025 | Sale | 14,467 | 55.95 | 809,429 | D |
| 31 Jan 2025 09:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 27 Jan 2025 | Sale | 8,700 | 57.007 | 495,961 | D |
| 29 Jan 2025 20:43 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 27 Jan 2025 | Sale | 13,812 | 54.76 | 756,345 | D |
| 29 Jan 2025 20:43 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 27 Jan 2025 | Sale | 5,059 | 55.62 | 281,382 | D |
| 29 Jan 2025 20:43 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 27 Jan 2025 | Sale | 12,379 | 56.97 | 705,232 | D |
| 29 Jan 2025 20:43 | AKRO | Akero Therapeutics Inc | LAMY PATRICK | Senior VP, Commercial Strategy | 27 Jan 2025 | Sale | 5,000 | 57.03 | 285,150 | D |
| 29 Jan 2025 20:43 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 27 Jan 2025 | Sale | 24,242 | 54.56 | 1,322,644 | D |
| 29 Jan 2025 20:43 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 27 Jan 2025 | Sale | 2,381 | 55.53 | 132,217 | D |
| 29 Jan 2025 20:43 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 27 Jan 2025 | Sale | 3,377 | 56.89 | 192,118 | D |
| 06 Jan 2025 14:08 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 02 Jan 2025 | Sale | 10,000 | 28.033 | 280,330 | D |
| 18 Dec 2024 21:03 | AKRO | Akero Therapeutics Inc | LAMY PATRICK | Senior VP, Commercial Strategy | 16 Dec 2024 | Sale | 1,000 | 29.13 | 29,130 | D |
| 18 Dec 2024 21:01 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 16 Dec 2024 | Sale | 9,074 | 29.107 | 264,117 | D |
| 18 Dec 2024 20:52 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 17 Dec 2024 | Sale | 3,800 | 31.098 | 118,172 | D |
| 12 Dec 2024 20:44 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 10 Dec 2024 | Sale | 2,368 | 30.79 | 72,911 | D |
| 12 Dec 2024 20:44 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 10 Dec 2024 | Sale | 2,450 | 31.03 | 76,024 | D |
| 12 Dec 2024 20:38 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 10 Dec 2024 | Sale | 2,503 | 30.79 | 77,067 | D |
| 12 Dec 2024 20:29 | AKRO | Akero Therapeutics Inc | LAMY PATRICK | Senior VP, Commercial Strategy | 10 Dec 2024 | Sale | 925 | 30.79 | 28,481 | D |
| 12 Dec 2024 20:28 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 10 Dec 2024 | Sale | 2,810 | 30.79 | 86,520 | D |
| 12 Dec 2024 20:26 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 10 Dec 2024 | Sale | 2,817 | 30.79 | 86,735 | D |
| 12 Dec 2024 20:24 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 10 Dec 2024 | Sale | 7,855 | 30.79 | 241,855 | D |
| 04 Dec 2024 19:36 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 02 Dec 2024 | Sale | 25,000 | 32.09 | 802,250 | D |
| 04 Dec 2024 19:34 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 02 Dec 2024 | Sale | 10,000 | 32.131 | 321,310 | D |
| 19 Nov 2024 21:57 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Nov 2024 | Sale | 8,761 | 27.694 | 242,627 | D |
| 19 Nov 2024 21:57 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Nov 2024 | Sale | 300 | 28.823 | 8,647 | D |
| 08 Nov 2024 17:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 06 Nov 2024 | Sale | 10,000 | 35.189 | 351,890 | D |
| 05 Nov 2024 09:04 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Nov 2024 | Sale | 34,943 | 31.254 | 1,092,109 | D |
| 05 Nov 2024 09:04 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Nov 2024 | Sale | 15,481 | 32.267 | 499,525 | D |
| 05 Nov 2024 09:04 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Nov 2024 | Sale | 292 | 32.937 | 9,618 | D |
| 05 Nov 2024 09:00 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 01 Nov 2024 | Sale | 81,280 | 31.472 | 2,558,044 | D |
| 05 Nov 2024 09:00 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 01 Nov 2024 | Sale | 27,086 | 32.499 | 880,268 | D |
| 01 Nov 2024 20:59 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 30 Oct 2024 | Sale | 4,515 | 32.526 | 146,855 | D |
| 01 Nov 2024 20:59 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 01 Nov 2024 | Sale | 15,485 | 32.619 | 505,105 | D |
| 18 Oct 2024 20:57 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 16 Oct 2024 | Sale | 24,992 | 31.136 | 778,151 | D |
| 18 Oct 2024 20:57 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 17 Oct 2024 | Sale | 3,103 | 31.118 | 96,559 | D |
| 18 Oct 2024 20:57 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 18 Oct 2024 | Sale | 63,313 | 31.527 | 1,996,069 | D |
| 18 Oct 2024 20:57 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 18 Oct 2024 | Sale | 226 | 32.12 | 7,259 | D |
| 16 Oct 2024 20:06 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 14 Oct 2024 | Sale | 40,000 | 30.152 | 1,206,080 | D |
| 16 Oct 2024 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Oct 2024 | Sale | 14,525 | 30.496 | 442,954 | D |
| 16 Oct 2024 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Oct 2024 | Sale | 300 | 30.927 | 9,278 | D |
| 16 Oct 2024 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 14 Oct 2024 | Sale | 6,136 | 30.029 | 184,258 | D |
| 03 Oct 2024 20:09 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Oct 2024 | Sale | 10,000 | 28.177 | 281,770 | D |
| 23 Sep 2024 18:00 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 20 Sep 2024 | Sale | 5,500 | 27.652 | 152,086 | D |
| 18 Sep 2024 21:19 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 18 Sep 2024 | Sale | 3,871 | 27.56 | 106,685 | D |
| 18 Sep 2024 21:19 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 17 Sep 2024 | Sale | 2,037 | 27.548 | 56,115 | D |
| 18 Sep 2024 21:19 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 16 Sep 2024 | Sale | 2,485 | 27.515 | 68,375 | D |
| 13 Sep 2024 17:16 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 10 Sep 2024 | Sale | 568 | 26.18 | 14,870 | D |
| 13 Sep 2024 17:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 10 Sep 2024 | Sale | 637 | 26.18 | 16,677 | D |
| 13 Sep 2024 17:13 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 10 Sep 2024 | Sale | 639 | 26.18 | 16,729 | D |
| 13 Sep 2024 17:11 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 10 Sep 2024 | Sale | 537 | 26.18 | 14,059 | D |
| 13 Sep 2024 17:10 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 10 Sep 2024 | Sale | 1,738 | 26.18 | 45,501 | D |
| 05 Sep 2024 16:08 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 03 Sep 2024 | Sale | 1,290 | 27.576 | 35,573 | D |
| 05 Sep 2024 16:08 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 03 Sep 2024 | Sale | 3,710 | 26.419 | 98,014 | D |
| 05 Sep 2024 16:05 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 03 Sep 2024 | Sale | 949 | 27.614 | 26,206 | D |
| 29 Aug 2024 16:30 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 27 Aug 2024 | Sale | 23,175 | 26.412 | 612,098 | D |
| 29 Aug 2024 16:30 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 26 Aug 2024 | Sale | 24,372 | 27.211 | 663,186 | D |
| 29 Aug 2024 16:30 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 26 Aug 2024 | Sale | 18,116 | 27.211 | 492,954 | D |
| 29 Aug 2024 16:30 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 26 Aug 2024 | Sale | 32,671 | 27.211 | 889,011 | D |
| 28 Aug 2024 11:11 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 26 Aug 2024 | Sale | 5,200 | 27.514 | 143,073 | D |
| 28 Aug 2024 11:11 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 23 Aug 2024 | Sale | 8,851 | 27.527 | 243,641 | D |
| 02 Aug 2024 21:32 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Aug 2024 | Sale | 1,969 | 27.23 | 53,616 | D |
| 02 Aug 2024 21:32 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Aug 2024 | Sale | 3,031 | 26.44 | 80,140 | D |
| 25 Jul 2024 17:54 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 25 Jul 2024 | Sale | 20,481 | 27.658 | 566,463 | D |
| 25 Jul 2024 17:54 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 25 Jul 2024 | Sale | 1,791 | 27 | 48,357 | D |
| 25 Jul 2024 17:54 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 24 Jul 2024 | Sale | 79,446 | 27.19 | 2,160,137 | D |
| 25 Jul 2024 17:54 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 24 Jul 2024 | Sale | 59,637 | 26.71 | 1,592,904 | D |
| 25 Jul 2024 17:54 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 23 Jul 2024 | Sale | 500 | 28.01 | 14,005 | D |
| 18 Jul 2024 21:41 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 16 Jul 2024 | Sale | 5,008 | 28.045 | 140,449 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)